Erich Bluhmki

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

Bernard Zinman, Christoph Wanner, John M. Lachin et al. · New England Journal of Medicine · 2015 · 12K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

Werner Hacke, Markku Kaste, Erich Bluhmki et al. · New England Journal of Medicine · 2008 · 6.6K citations · Full text

Medicine, Neurology, Neurocritical Care +11

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)

Werner Hacke, Markku Kaste, Cesare Fieschi et al. · The Lancet · 1998 · 3.7K citations

Medicine, Neurology, Pharmacotherapy +12

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials

Werner Hacke, Geoffrey A. Donnan, Cesare Fieschi et al. · The Lancet · 2004 · 2.6K citations

Medicine, Neurology, Meta-analysis +6

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

Kennedy R. Lees, Erich Bluhmki, Rüdiger von Kummer et al. · The Lancet · 2010 · 2.2K citations

Medicine, Neurology, Meta-analysis +7